---

COVID-19 is testing our health care system in new ways — raising concerns about equity, surge capacity, the social safety net, and data collection. The drug supply chain is no exception. Drug shortages — particularly for generic drugs — are nothing new. But several factors are now straining our supply chain, leading to an increased chance of shortages and exposing risks.        
Source: The Commonwealth Fund: Blog - Category: International Medicine & Public Health Authors: Source Type: blogs